Once a year it is worth looking up from the daily work and taking in the big picture: how big has this market become, where is it heading, and what does that mean for a decision-maker? We have collected the latest available figures – with sources indicated throughout. Data reflect the state of play in July 2026.
HUF 59 billion – and almost all of it corporate
According to the health insurance data service of MABISZ (the Association of Hungarian Insurance Companies), annual premium income from service-financing health insurance reached HUF 59.1 billion in 2025. The number itself is telling, but its composition even more so: HUF 55.5 billion – nearly 94% – comes from group contracts, typically employer-paid. Hungarian health insurance is thus overwhelmingly a corporate genre, not a retail one: companies buy it as a benefit for their employees.
One million insured – but no longer growing by itself
According to MABISZ data, the number of insured stood at around 1.06 million at the end of 2025 (of which 1.03 million under group schemes). That marks a huge journey – according to a KPMG analysis, market premium income grew from roughly HUF 3 billion to HUF 25 billion between 2000 and 2021, and has more than doubled since – but also an important turning point: in 2025 the number of insured declined slightly, by 1.2%, while premium income kept growing. In plain terms: the market is no longer expanding through new masses joining, but through rising premiums and richer packages. For anyone contracting or renegotiating today, this is the key context: the premium negotiation carries more weight than ever.
The big picture: private healthcare marching towards a trillion
Health insurance is embedded in a much larger market. A market overview published on Portfolio in July 2026 estimates that the entire Hungarian private healthcare market was already close to the HUF 1,000 billion mark in 2025. After the stall of 2022–23 the market is growing again, and the engine of growth is increasingly voluntary, organised financing: health-fund and insurance-type spending grew, according to the overview, by around 12% in 2024, faster than households' out-of-pocket outlays. Meanwhile, spectacular consolidation is under way on the provider side – in 2026, for instance, one of the market's largest players acquired one of the largest diagnostics networks – which may in the longer run affect both prices and network composition.
What does all this mean for a company director?
- The genre is proven: with a million insured and 94% corporate contracts, group health insurance is no longer a pioneering experiment but an established HR tool.
- Private care is getting more expensive: compared to out-of-pocket prices, the bargaining position of organised, insurer-mediated access keeps gaining value.
- The premium negotiation has appreciated: with premium levels rising, tendering and review (where warranted or on request) are no longer a luxury but the baseline.
- Taxation has remained favourable: group health insurance is still one of the most efficient benefit forms compared to salary – see the detailed calculation in our downloadable tax guide.
Sources: MABISZ health insurance data service (2025 Q4); Portfolio.hu market overview (July 2026); KSH (Hungarian Central Statistical Office) health expenditure statistics; KPMG analysis (2023). Figures are the latest public disclosures available at the time of writing.
A question about your own team? Book a free 20-minute consultation →
